These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15830034)

  • 1. Renal and humoral pathophysiological actions of angiotensin II in congestive heart failure.
    Mirzoyev Z; Anavekar NS; Chen HH
    Timely Top Med Cardiovasc Dis; 2005 Apr; 9():E9. PubMed ID: 15830034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and humoral pathophysiological actions of angiotensin II in congestive heart failure.
    Mirzoyev Z; Anavekar NS; Chen HH
    Drugs Today (Barc); 2005 Feb; 41(2):129-39. PubMed ID: 15821784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].
    Sandmann S; Unger T
    Drugs; 2002; 62 Spec No 1():43-52. PubMed ID: 12036388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activation of the renin-angiotensin-aldosterone system in heart failure].
    Volpe M; Tocci G; Pagannone E
    Ital Heart J; 2005 May; 6 Suppl 1():16S-23S. PubMed ID: 15945296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
    Červenka L; Melenovský V; Husková Z; Škaroupková P; Nishiyama A; Sadowski J
    Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):795-807. PubMed ID: 25969338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptors-antagonists, molecular biology, and signal transduction.
    Jagadeesh G
    Indian J Exp Biol; 1998 Dec; 36(12):1171-94. PubMed ID: 10093499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy].
    Castro-Chaves P; Leite-Moreira AF
    Rev Port Cardiol; 2004 May; 23 Suppl 2():II61-77. PubMed ID: 15222251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin-aldosterone system: fundamental aspects and clinical implications in renal and cardiovascular disorders.
    Perazella MA; Setaro JF
    J Nucl Cardiol; 2003; 10(2):184-96. PubMed ID: 12673184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive and maladaptive actions of angiotensin II in patients with severe congestive heart failure.
    Packer M
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):66-73. PubMed ID: 3037891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
    Cody RJ
    Drugs; 1984 Aug; 28(2):144-69. PubMed ID: 6205842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between the adrenergic and renin-angiotensin-aldosterone-systems.
    van Zwieten PA; de Jonge A
    Postgrad Med J; 1986; 62 Suppl 1():23-7. PubMed ID: 3534860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local Renin Angiotensin Aldosterone Systems and Cardiovascular Diseases.
    De Mello WC
    Med Clin North Am; 2017 Jan; 101(1):117-127. PubMed ID: 27884223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease.
    Mancia G; Dell'Oro R; Quarti-Trevano F; Scopelliti F; Grassi G
    J Hypertens Suppl; 2006 Mar; 24(1):S51-6. PubMed ID: 16601574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction.
    Sciarretta S; Paneni F; Palano F; Chin D; Tocci G; Rubattu S; Volpe M
    Clin Sci (Lond); 2009 Mar; 116(6):467-77. PubMed ID: 19200056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronobiology and Pharmacologic Modulation of the Renin-Angiotensin-Aldosterone System in Dogs: What Have We Learned?
    Mochel JP; Danhof M
    Rev Physiol Biochem Pharmacol; 2015; 169():43-69. PubMed ID: 26428686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
    Asmar R; Madonna O; Brisac AM; Benetos A; Laurent S
    Therapie; 1998; 53(3):253-70. PubMed ID: 9773125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II-mediated signal transduction pathways.
    Saito Y; Berk BC
    Curr Hypertens Rep; 2002 Apr; 4(2):167-71. PubMed ID: 11884273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
    Brewster UC; Perazella MA
    Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.
    Watkins L; Burton JA; Haber E; Cant JR; Smith FW; Barger AC
    J Clin Invest; 1976 Jun; 57(6):1606-17. PubMed ID: 180056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.